Join us on the official University of Michigan Rose Bowl Tour!

New Biomarker Strategy Devised to Screen for, Diagnose Deadly Heart Complication from Cancer Treatment

December 20, 2022


Read time:

5-15 mins
Presented by Health Lab

Researchers at the University of Michigan have developed a strategy involving biomarkers to screen for a rare and deadly complication associated with antibodies in cancer treatment. Salim Hayek, M.D., senior author of the study and medical director of the University of Michigan Health Frankel Cardiovascular Center Clinic, discusses the threat of myocarditis with cancer treatments and the impacts that the new biomarker strategy could have in treating it.



More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.